ArticleAmerican journal of ophthalmology2025
Comment on "Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration".
Tiarnán D L KeenanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.